Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Plos One|November 3, 2021
Disulfiram and copper combination therapy targets NPL4, cancer stem cells and extends survival in a medulloblastoma modelRiccardo Serra, Tianna Zhao, Sakibul Huq, et al.
Proceedings of Spie--The International Society for Optical Engineering|March 28, 2022
Development of a Smart Hospital Assistant: Integrating Artificial Intelligence and a Voice-User Interface for Improved Surgical OutcomesJeong Hun Kim, Richard Um, Jonathan Liu, et al.
Medical Physics|August 3, 2015
Quantitative correlational study of microbubble-enhanced ultrasound imaging and magnetic resonance imaging of glioma and early response to radiotherapy in a rat modelChen Yang, Dong-Hoon Lee, Antonella Mangraviti, et al.
Journal of Neurosurgery|August 4, 2018
Evaluation of an in vivo model for ventricular shunt infection: a pilot study using a novel antimicrobial-loaded polymerRajiv R Iyer, Noah Gorelick, Karen Carroll, et al.
Molecular Cancer Therapeutics|December 4, 2025
Inhibition of CDKs Enhances Efficacy of Anti-EGFR Therapy in ChordomaTianna Zhao, Riccardo Serra, Michelle Guo, et al.
Nature Medicine|December 21, 2010
Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptidesJinyuan Zhou, Erik Tryggestad, Zhibo Wen, et al.
Neuro-Oncology|July 6, 2011
Local delivery of rapamycin: a toxicity and efficacy study in an experimental malignant glioma model in ratsBetty Tyler, Scott Wadsworth, Violette Recinos, et al.
Experimental Hematology & Oncology|January 30, 2024
GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironmentCharles H Williams, Leif R Neitzel, Jessica Cornell, et al.
Small Science|January 7, 2026
DNA-Loaded Nanoparticles Reprogram the Tumor Immune Microenvironment to Treat Brain TumorsJoanna Yang, Divyaansh Raj, Hasan Slika, et al.
Oncotarget|November 9, 2017
Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patientsAvadhut D Joshi, Rachel C Botham, Lisa J Schlein, et al.
Pageof 12